×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
Yahoo Finance
The latest analyst coverage could presage a bad day for Denali Therapeutics Inc. ( NASDAQ:DNLI ), with the analysts...
2 weeks ago
Revenues Not Telling The Story For Denali Therapeutics Inc. (NASDAQ:DNLI) After Shares Rise 25%
Simply Wall Street
Denali Therapeutics Inc. ( NASDAQ:DNLI ) shareholders would be excited to see that the share price has had a great...
5 days ago
Edmond DE Rothschild Holding S.A. Purchases 65,800 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
MarketBeat
Edmond DE Rothschild Holding S.A. grew its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 65.9% during the...
5 hours ago
Q2 2024 EPS Estimates for Denali Therapeutics Inc. (NASDAQ:DNLI) Raised by Analyst
Defense World
Read Q2 2024 EPS Estimates for Denali Therapeutics Inc. (NASDAQ:DNLI) Raised by Analyst at Defense World.
1 day ago
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company...
3 weeks ago
Denali Therapeutics: MPS Treatment Program Continues With End Of 2024 Data (NASDAQ:DNLI)
Seeking Alpha
Denali Therapeutics Inc.'s DNL-310 is currently being explored in an ongoing phase 2/3 COMPASS study for treatment of patients with MPS II;...
2 weeks ago
Sanofi and Denali's ALS therapy misses primary endpoint in Phase II
Clinical Trials Arena
The Phase II trial for amyotrophic lateral sclerosis (ALS) therapy failed to show improvement in ALS functional rating scale.
3 months ago
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
Yahoo Finance
Key Insights Using the 2 Stage Free Cash Flow to Equity, Denali Therapeutics fair value estimate is US$30.74 Denali...
1 month ago
Teacher Retirement System of Texas Decreases Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Defense World
Read Teacher Retirement System of Texas Decreases Stake in Denali Therapeutics Inc. (NASDAQ:DNLI) at Defense World.
2 days ago
Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the ...
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company...
4 weeks ago